- ASSISTANT PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- Gynecologic Oncology
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Hagopian is Chief of Gynecologic Oncology at The Elmhurst Hospital Center and The Queens Hospital Center where he is active in teaching residents and medical students. He is also clinically active at Mount Sinai Hospital Affiliates in Westchester and Orange County, New York.
Dr. Hagopian is certified by the American Board of Obstetrics and Gynecology in Gynecologic Oncology and Obstetrics and Gynecology. He is also a Fellow of the American College of Surgeons.
MD, Wayne State University
Residency, Obs/ Gyn
Northwestern Univ Medical School
Fellowship, Gynecology Oncology
Anderson Cancer Center
Fellowship, Gynecology Oncology
Mount Sinai Hospital
Glaxo Wellcome Oncology Clinical Research Scholar
Alpha Omega Alpha
Graduation with Distinction in Biomedical Research
Roger Walker Scholarship
David S. Diamond Award in Obstetrics and Gynecology
Medical School Class Honors
Wayne State University Alumni Research Fellowship
M. D. Anderson Cancer Center Office of Education Clinical Trainee Research Award
M. D. Anderson Cancer Center University Cancer Foundation Fellowship
Berry E, Hagopian GS, Lurain JR. Vaginal metastases in gestational trophoblastic neoplasia. J. Repro. Med 2008; 53: 487-492.
Higgins SC, Zakashansky K, Bovbjerg DH, Hagopian GS. Unexpected vomiting in a women contemplating a second course of chemotherapy for carcinosarcoma of the uterus. J. Pain Symptom Mange 2008; 36: e1-2.
Kalir T, Rahaman J, Hagopian G, Demopoulos R, Cohen C, Burstein D. Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant Fallopian tube epithelia, with comparison to ovarian carcinomas. Arch. Path. Lab. Med 2005; 129: 651-654.
Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: Modulation with 1R, 2R-diaminocyclohexane (DACH)-diacetato-dichloro-Pt(IV). Clin. Cancer Res 1999; 5: 655-663.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Hagopian did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.